- $21.24bn
- $20.59bn
- $2.54bn
- 92
- 23
- 85
- 75
Annual income statement for Nutanix, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
R2021 July 31st | R2022 July 31st | 2023 July 31st | 2024 July 31st | 2025 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,394 | 1,581 | 1,863 | 2,149 | 2,538 |
| Cost of Revenue | |||||
| Gross Profit | 1,102 | 1,260 | 1,531 | 1,825 | 2,203 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,056 | 2,105 | 2,059 | 2,141 | 2,365 |
| Operating Profit | -662 | -524 | -196 | 7.56 | 173 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1,017 | -780 | -234 | -101 | 212 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1,036 | -799 | -255 | -125 | 188 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1,036 | -799 | -255 | -125 | 188 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1,036 | -799 | -255 | -125 | 188 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -5 | -3.4 | -0.963 | -0.461 | 0.669 |